Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HINATA: Follitropin alfa + lutropin alfa vs hMG for follicular development in LH/FSH deficiency
jRCT2031250671Recruiting
- Sponsor
- Merck KGaA
- Start
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of follitropin alfa + lutropin alfa in female infertility (2 arms), sponsored by Merck KGaA. Primary endpoint: Total number of oocytes retrieved. Started Jan 2026; status: recruiting.
02
Drugs
follitropin alfa + lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on jRCT2031250671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250671.